Jessica Vondrak, MD

She/They
Hospital Medicine, Hospice and Palliative Care
Accepting new patients
Sees patients age 18 and up
Penn Hospital Medicine Pennsylvania Hospital
View 1 additional location
Call 800-789-7366
Headshot of Jessica Vondrak, MD
Penn Medicine Provider

About me

  • Clinical Assistant Professor of Medicine

My education and training

  • Medical School: Geisinger Commonwealth School of Medicine
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Dr. Vondrak is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Vondrak J, Radcliff JA, Haley EM Exploring the Role of Buprenorphine-naloxone Therapy in Patients with Opioid Use Disorder and Serious Illness-related Pain: A Case Report , Poster presented at: Annual Assembly of Hospice and Palliative Care, American Academy of Hospice and Palliative Medicine: 2021

Recio-Boiles, A., Vondrak, J., Veeravelli, S., Mancuso, J. J., Saboda, K., Roe, D. J., Riaz, I. B., Scott, A. J., Elquza, E., McBride, A., Babiker, H. M. Analyzing outcomes of neoadjuvant and adjuvant treatment for borderline-resectable pancreatic adenocarcinoma in the perioperative period at an academic institution , Ann Pancreat Cancer, 3(2): 2020

Recio-Boiles A, Veeravelli S, Vondrak J, Babiker HM, Scott AJ, Shroff RT, Patel H, Elquza E, McBride A Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolism. , World J Gastrointest Oncol, 11(10): 2019,866-876

Babiker HM, Byron SA, Hendricks WPD, Elmquist WF, Gampa G, Vondrak J, Aldrich J, Cuyugan L, Adkins J, De Luca V, Tibes R, Borad MJ, Marceau K, Myers TJ, Paradiso LJ, Liang WS, Korn RL, Cridebring D, Von Hoff DD, Carpten JD, Craig DW, Trent JM, Gordon MS E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases , Invest New Drugs, 37(4): 2019,636-645

Recio-Boiles A, Nallagangula A, Veeravelli S, Vondrak J, Saboda K, Roe D, Elquza E, McBride A, Babiker HM Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios inversely correlate to clinical and pathologic stage in patients with resectable pancreatic ductal adenocarcinoma. , Ann Pancreat Cancer, 2(8): 2019

Coffman N, Vondrak J Medical Image of the Month: Malignant Pericardial Effusion , Southwest J Pulm Crit Care, 17(5): 2018

Vondrak J, Barbee B Medical Image of the Week: Pulmonary Vein Thrombosis , Southwest J Pulm Crit Care, 14(5): 2017,228-9

Alejandro Recio Boiles, Jessica Vondrak, Kristopher J. Abbate, Hani M. Babiker, Aaron J. Scott, Ali McBride, Emad Elquza Clinical Risk Factors Associated with Recurrent Venous Thromboembolism and Major Bleeding in Gastrointestingal Cancer Patients Receiving DOACs for Secondary Thromboprophylaxis , Blood: 2017